Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Total hip replacement surgery is one of the most common orthopedic interventions. Proper anaesthesia and adequate analgesia is one of the key interests of attending anaesthetist. Recent studies show that ultrasound guided suprainguinal fascia iliaca compartment block may play a significant role in proper management of pain after these procedures. The aim of this study was to assess the clinical usefulness and compare different methods of anaesthesia for total hip replacement surgery via posterolateral approach.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Opioid and non opioid postoperative analgesia. | Placebo Comparator | Group of patients with opioid and non opioid based postoperative analgesia without preoperative regional anaesthesia and dexamethasone. |
|
| Regional anaesthesia, opioid and non opioid postoperative analgesia. | Experimental | Group of patients with opioid and non opioid based postoperative analgesia with preoperative regional anaesthesia and without preoperative dexamethasone. |
|
| Regional anaesthesia, dexamethasone, opioid and non opioid postoperative analgesia | Experimental | Group of patients with opioid and non opioid based postoperative analgesia with preoperative regional anaesthesia and dexamethasone. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Opioid and non opioid postoperative analgesia. | Other | Postoperative analgesia will be based on opioid and non opioid analgesics according to standardised protocol. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Opioid consumption [mg] | Postoperative opioid consumption was noted. | 48 hours |
| Opioid related adverse effects | Postoperative incidence of nausea, vomiting, constipation and apnea were noted. | 48 hours |
| Hospital stay [days] | Total length of hospital stay was noted. | 31 days |
| Measure | Description | Time Frame |
|---|---|---|
| Likert scale | Likert scale value was noted at the discharge. Value of 1 corresponded with strong dissatisfaction, value of 2 with dissatisfaction, value of 3 with neither satisfaction nor dissatisfaction, value of 4 with satisfaction, value of 5 with strong satisfaction. | 31 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wojciech Gola, MD | Head of the Department of Anesthesia and Intensive Care Unit, Saint Lucas Hospital, Konskie, Poland | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Saint Lucas Hospital | Gmina Końskie | Świętokrzyskie Voivodeship | 20-206 | Poland |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34064427 | Derived | Gola W, Bialka S, Owczarek AJ, Misiolek H. Effectiveness of Fascia Iliaca Compartment Block after Elective Total Hip Replacement: A Prospective, Randomized, Controlled Study. Int J Environ Res Public Health. 2021 May 4;18(9):4891. doi: 10.3390/ijerph18094891. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Fascia iliaca compartment block | Other | Ultrasound guided suprainguinal fascia iliaca compartment block will be performed using 0.375% ropivacaine and 5ug/ml adrenaline according to standardised protocol. |
|
| Dexamethasone | Drug | Dexamethasone will be administered preoperatively in a dose of 0,1 mg/kg. |
|
| ID | Term |
|---|---|
| D000377 | Agnosia |
| ID | Term |
|---|---|
| D010468 | Perceptual Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D000701 | Analgesics, Opioid |
| D003907 | Dexamethasone |
| ID | Term |
|---|---|
| D009294 | Narcotics |
| D002492 | Central Nervous System Depressants |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D000700 | Analgesics |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |
| D011246 | Pregnadienetriols |
| D011245 | Pregnadienes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 | Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D013259 | Steroids, Fluorinated |
Not provided
Not provided